Nitric Oxide-dependent Regulation of Pro-inflammatory Cytokines in Group B Streptococcal Inflammation of Rat Lung
Overview
Affiliations
Group B Streptococcus (GBS) infection leading to sepsis and lung injury is a major cause of neonatal morbidity and mortality. Lung injury may result from overproduction of pro-inflammatory mediators (cytokines), caused by nitric oxide (NO). Our objective was to characterize the molecular signaling events involving the pro-inflammatory mediators interleukin-6 (IL-6) and macrophage inflammatory protein (MIP-2) in the presence of aminoguanidine (AG), an inducible nitric oxide synthase (iNOS) specific inhibitor, in lung tissue from GBS-treated young rats. Changes in iNOS mRNA, lactic acid, and rectal temperature were determined as markers of the inflammatory response. Expression and regulation of IL-6 and MIP-2 mRNA in lung tissue were studied by RT-PCR with densitometry analysis. GBS treatment of young rats induced the expression of pro-inflammatory mediators IL-6 (6-fold) and MIP-2 (3-fold) in lung tissue compared to controls. AG decreased IL-6 and MIP-2 expression. Addition of L-arginine (L-arg) reversed the AG effect on IL-6 and MIP-2 expression. These data suggest a role for the nitric oxide pathway in the overproduction of pro-inflammatory mediators IL-6 and MIP-2 during GBS-induced lung inflammation. This pathway may be responsible for the initiation of lung injury.
Goh K, Desai D, Thapa R, Prince D, Acharya D, Sullivan M FEMS Microbiol Rev. 2024; 48(3).
PMID: 38678005 PMC: 11098048. DOI: 10.1093/femsre/fuae009.
Regulatory Role of Nitric Oxide in Cutaneous Inflammation.
Man M, Wakefield J, Mauro T, Elias P Inflammation. 2022; 45(3):949-964.
PMID: 35094214 PMC: 11249049. DOI: 10.1007/s10753-021-01615-8.
Barreira-Silva P, Melo-Miranda R, Nobrega C, Roque S, Serre-Miranda C, Borges M Front Immunol. 2022; 12:696415.
PMID: 34987496 PMC: 8721011. DOI: 10.3389/fimmu.2021.696415.
Salimi U, Dummula K, Tucker M, Dela Cruz C, Sampath V Am J Respir Cell Mol Biol. 2021; 66(2):137-145.
PMID: 34644520 PMC: 8845139. DOI: 10.1165/rcmb.2021-0353PS.
Ko H, Lee S, Jee W, Jung J, Kim K, Jung H Pharmaceutics. 2021; 13(7).
PMID: 34371720 PMC: 8309055. DOI: 10.3390/pharmaceutics13071028.